Although this study presents limitations due to the use of cell cultures, it shows potential therapeutic implications for HSP, providing crucial a foundation for assessing the effects of MDM2 inhibition in SPG4-HSP neurons and animal models. Here, MDM2 is linked to hereditary spastic paraplegia.